banner
Recombinant Bifidobacterium longum subsp α2,3/6/8 sialyl glycosidase, E. coli
Inquiry

Cat. No.: X23-03-YW102

Recombinant Bifidobacterium longum subsp α2,3/6/8 sialyl glycosidase, E. coli

Synonym: SpNanA

  • Enzyme Commission Number: 3.2.1.18
img
Product Size
1 U; 5 U; 25 U
Price
Datasheet
MSDS
Properties
Description
It is a recombinant Bifidobacterium longum subsp α2,3/6/8 sialyl glycosidase produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoprotein in vitro.
Unit Definition
One unit will catalyze the formation of 1 μmol Neu5Ac from Neu5Acα2,3/6/8 Neu5Ac in one minute at 37°C.
Source
Bifidobacterium longum subsp
Form
Lyophilized powder
Applications
α2, 3/6/8 Neuraminidase catalyzes the hydrolysis of α2, 3, α2, 6, α2, 8 linked sialic acid residues from glycoproteins and oligosaccharides. And as a glycoengineering tool to modify glycoproteins in vitro.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0